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Objective Split-hand/foot malformation type 1 is an
autosomal dominant condition with reduced penetrance
and variable expression. We report three individuals from
two families with split-hand/split-foot malformation
(SHFM) in whom next generation sequencing was
performed to investigate the cause of their phenotype.
Methods and results The ﬁrst proband has a de
novo balanced translocation t(2;7)(p25.1;q22) identiﬁed
by karyotyping. Whole genome sequencing showed that
the chromosome 7 breakpoint is situated within the
SHFM1 locus on chromosome 7q21.3. This separates the
DYNC1I1 exons recently identiﬁed as limb enhancers in
mouse studies from their target genes, DLX5 and DLX6.
In the second family, X-linked recessive inheritance was
suspected and exome sequencing was performed to
search for a mutation in the affected proband and his
uncle. No coding mutation was found within the SHFM2
locus at Xq26 or elsewhere in the exome, but a 106 kb
deletion within the SHFM1 locus was detected through
copy number analysis. Genome sequencing of the
deletion breakpoints showed that the DLX5 and DLX6
genes are disomic but the putative DYNC1I1 exon 15
and 17 enhancers are deleted.
Conclusions Exome sequencing identiﬁed a 106 kb
deletion that narrows the SHFM1 critical region from 0.9
to 0.1 Mb and conﬁrms a key role of DYNC1I1 exonic
enhancers in normal limb formation in humans.
Split-hand/split-foot malformation is a congenital
limb abnormality characterised by the absence of
one or more median rays or digits that results in
cone-shaped clefts of hands and/or feet. It is often
accompanied by other limb anomalies including
monodactyly, syndactyly, and aplasia or hypoplasia
of the phalanges, metacarpals, and metatarsals. The
malformation can be isolated or syndromic (intel-
lectual disability in 33%, craniofacial malforma-
tions in >35%, and deafness in 35%; split-hand/
split-foot malformation 1D (SHFM1D), OMIM
#220600), and the severity can be variable
between patients as well as between different limbs
of the same individual. The condition is genetically
heterogeneous with six loci deﬁned, including the
SHFM1 locus 7q21 (OMIM #183600) and
SHFM2 locus Xq26 (OMIM #313350). The 7q21
locus contains the candidate SHFM genes distal-less
homeobox 5 and 6 (DLX5/6); double-knockout
mice exhibit severe skeletal abnormalities and die
shortly after birth,1 while a homozygous missense
mutation in DLX5 has recently been reported to
cause split-hand/foot malformation and hearing
loss in a consanguineous family.2 No other known
DLX5/6 coding mutations leading to SHFM1 have
been reported to date. Several chromosomal abnor-
malities have been reported in this region that lead
to SHFM1; some do not affect the DLX5/6 genes
and are thought to disrupt one or more regulatory
elements, or result in a physical separation of
such elements from the most likely target genes,
DLX5/6. The smallest reported deletion is of
880 kb encompassing SLC25A13 and part of
DYNC1I1, but leaving DLX5 and DLX6 intact.3 In
the developing limb, both Dlx5 and Dlx6 are
thought to be regulated by the transcription factor
tumour protein p634 and TP63 mutations cause
split-hand/split-foot malformation 4 (SHFM4;
OMIM #605289). An enhancer element with a
p63 binding site has been reported within the
SHFM1 locus 300 kb proximal to Dlx5/6.3
Recent studies in mouse and zebraﬁsh models
identiﬁed novel tissue-speciﬁc enhancers that cor-
relate with limb, craniofacial and hearing pheno-
types observed in individuals with chromosomal
rearrangements.5 6 Two of these enhancers are
located within the coding exons 15 and 17 of
Dync1i1 (dynein, cytoplasmic 1, intermediate chain
1), a gene that is not expressed during limb devel-
opment. DYNC1I1 eExon (exonic enhancer) 15 is
marked by an enhancer chromatin signature and
physically interacts with the Dlx5/6 promoter
regions 900 kb distal to DYNC1I1, speciﬁcally in
the limb.5 An additional multi-tissue enhancer was
identiﬁed in an intron of Slc25a13 (solute carrier
family 25 member 13), driving the expression of
Dlx5/6 in otic vesicle, forebrain, branchial arch and
limb—a pattern that correlates with some but not
all SHFM1 phenotypes observed in humans.6
We studied three patients with SHFM from two
families. Informed consent was obtained from all
participants or their parents. Proband 1 had split-
hand/split-foot malformation (ﬁgure 1A) affecting
three limbs, and sensorineural deafness. Array com-
parative genomic hybridisation (CGH) analysis
indicated normal dosage, but subsequent karyotyp-
ing showed a de novo balanced translocation (2;7)
(p25.1;q22). Paired-end whole genome sequencing
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was performed on a single lane of Illumina HiSeq 2000 to map
the translocation breakpoints. We obtained average coverage of
eight reads per base, and looked for reads where one of the pair
mapped at or near the chr2 region, and the other at or near the
chr7 region. We identiﬁed seven such split pair reads, and a
further six reads mapping directly over the translocation break-
points (see online supplementary ﬁgure 1A) which showed that
the chromosome 7 breakpoint is within 7q21.3, not 7q22. The
precise breakpoints were conﬁrmed by Sanger sequencing
of PCR products spanning the breakpoints (see online
supplementary ﬁgure 1B), and the translocation was deﬁned as
t(2;7)(p25.1;q21.3)(oNC_000007.13:g.96229309::CTCTGC::
NC_000002.11:g.10585833;NC_000007.13:g.96229314::G::
oNC_000002.11:g.10585828). The chromosome 2 breakpoint
is located within intron 1 of the ornithine decarboxylase 1
(ODC1) gene encoding the rate-limiting enzyme of the polya-
mine biosynthesis pathway. A polymorphism in this gene has
been associated with colon cancer risk,7 but there are no
reported disease-causing mutations. The chromosome 7 break-
point is situated within the 7q21.3 SHFM1 locus, in the inter-
genic region 370 kb upstream of DLX5/6 genes and 500 kb
downstream of the DYNC1I1 exons 15 and 17 identiﬁed as
exonic enhancers in mice and zebraﬁsh (ﬁgure 2).5
In family 2 the proband and his affected uncle have isolated
split-hand/split-foot malformation affecting one or three limbs
(ﬁgure 1B). The uncle has complained of mild hearing difﬁculty
for about 5 years and an audiogram revealed unilateral high tone
loss; however, he used to work in a machine tool environment,
which may have been the cause. Array CGH analysis using an
Agilent 44K oligo array was normal and the mode of inheritance
was thought most likely to be X-linked recessive. We performed
exome sequencing of both affected individuals to look for shared
mutations within the putative SHFM2 region at Xq26.3, but
failed to ﬁnd a likely causal mutation at Xq26 or elsewhere
within the exome. We then carried out copy number analysis of
the entire chromosome 7 using the method published by Nord
et al8 and identiﬁed a single shared ∼100 kb deletion on 7q21,
partially encompassing exons 11–18 of the SLC25A13 gene and
exons 14–17 of the DYNC1I1 gene (see online supplementary
ﬁgure 1C). Biallelic mutations in SLC25A13 cause citrin deﬁ-
ciency, an adult- or neonatal-onset metabolic disorder, while
homozygous Slc25a13 knock-out mice show no skeletal defects9;
hence a heterozygous partial deletion of this gene is unlikely to
be associated with SHFM1 phenotype. The DYNC1I1 gene
encodes the intermediate chain 1 subunit of the cytoplasmic
dynein motor protein complex, the primary motor protein
responsible for retrograde axonal transport in neurons. Since this
gene is not expressed in the developing limb a partial gene dele-
tion is not predicted to cause split-hand/foot malformation.
However, the deleted DYNC1I1 exons include the enhancers
identiﬁed by Birnbaum et al.5 Visual inspection of the reads indi-
cated that the breakpoints were not located within the exons, so
in order to accurately map the deletion we performed paired-end
whole genome sequencing of the proband. We looked for read
pairs with large (>100 kb) insert sizes within the introns on
either side of the last deleted exon, and identiﬁed four such read
pairs, as well as two reads mapping directly across the break-
points (see online supplementary ﬁgure 1D). Sanger sequencing
of a PCR product spanning the breakpoints conﬁrmed a
105 935bp deletion; NC_000007.13:g.95704812_95810747del
(see online supplementary ﬁgure 1E). The presence of the junc-
tion fragment was conﬁrmed in the two affected individuals and
also in four non-penetrant unaffected family members (ﬁgure
1C). Incomplete penetrance of rearrangements affecting the
Figure 1 Variable malformation severity and incomplete penetrance in the two split-hand/split-foot malformation 1 (SHFM1) families. (A) Hands and
feet of the family 1 patient with a de novo translocation. The right hand has a deﬁcient central ray (upper left image). The left hand is normal (upper
right image). The right foot shows deﬁciency of the second and third rays, partial syndactyly of toes 4–5, and a large great toe (lower left). The left foot
shows syndactyly of toes 1–2, and deﬁciency of the terminal phalanx of the third toe with anonychia (lower right). (B) Hands and feet of the family 2
patients with the deletion. In the proband, both feet and the right hand are normal. In the left hand, the central ray is deﬁcient, and in the ring ﬁnger
there is camptodactyly at the proximal interphalangeal joint (left image). The proband’s maternal uncle is severely affected, with the exception of his
left foot, which is normal. His left hand is similar to that of his affected nephew, with deﬁciency of the central ray, camptodactyly of the ring ﬁnger,
and some shortening and stiffness of the second (index) ﬁnger. In the right hand the second and third rays are absent and there is fusion/syndactyly of
rays 4–5 with a single digit. The right foot is also severely affected, with absence of the second and third rays, and fusion of rays 4–5 with a single
digit (right image). The uncle’s affected daughter (no images) has deﬁciency of the central ray of the right hand and right foot, with the left hand and
left foot unaffected. The right hand closely resembles the left hands of her father and proband. (C) Family 2 pedigree and the results of junction
fragment PCR sequencing of both affected (black shapes) and unaffected (white shapes) family members, showing incomplete penetrance of the
mutation. The two individuals in whom we performed exome sequencing are the proband (black arrow) and his affected uncle. After the deletion was
identiﬁed, a third individual (the ﬁrst female affected in this family) was diagnosed with suspected split-hand/split-foot malformation on routine
antenatal ultrasound. She has missing central rays (third digit) of the right hand and right foot only.
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SHFM1 locus has been reported previously.10–13 After the dele-
tion was identiﬁed, a third affected individual was diagnosed
during routine antenatal scanning (ﬁgure 1C). At birth, this baby
girl was noted to have a normal left hand and left foot. However,
the right hand and right foot were affected to a similar extent,
with absence of the central ray and, in the hand, camptodactyly
affecting the ring ﬁnger, as well as the second (index) ﬁnger to a
lesser extent.
The 106 kb deletion identiﬁed in both affected members of
the second family is the smallest deletion identiﬁed within the
SHFM1 region. It results in haploinsufﬁciency for most 30
DYNC1I1 exons 14–17. This result suggests that DYNC1I1
exons 15 and 17 act as tissue-speciﬁc enhancers of DLX5/6
expression in humans as well as in mouse and zebraﬁsh. DLX5
and DLX6 are transcription factors essential for epidermal mor-
phogenesis and limb development, and targeted inactivation of
the Dlx5/6 gene pair in mice results in severe limb, craniofacial,
and axial skeletal defects.1 However, only a single human muta-
tion in DLX5/6 has been identiﬁed to date,2 and the reported
chromosomal aberrations leading to SHFM1 encompass but the
breakpoints do not directly disrupt either of the two genes, sug-
gesting that DLX5/6 cis-regulatory elements play a crucial role
in human limb development. Interestingly, the deletion in family
2 does not extend to the p63 binding site in the enhancer iden-
tiﬁed by Kouwenhoven et al.3
In addition to DYNC1I1 eExons 15 and 17, several other puta-
tive mouse and zebraﬁsh enhancers have been identiﬁed within
the minimal SHFM1 region that extends between the DYNC1I1
and DLX5/6 genes.6 The conserved sequences were shown to
drive Dlx5/6 expression in the developing limb, ﬁn, brain, ear,
branchial arch (gill and jaw), and genital tissues, and the position
of these functional enhancers compared to SHFM1-associated
chromosome rearrangements suggests that their disruption
might, in some cases, explain the additional clinical phenotypes
such as hearing loss and craniofacial defects.6 Within intron 14
of SLC25A13 is an enhancer with activity in the otic vesicle
(ﬁgure 2) that might explain the sensorineural deafness in
proband 1 through the physical separation of this enhancer from
the DLX5/6 genes. Although the deletion in family 2 also
includes SLC25A13 intron 14, only one of the six individuals
with the deletion is reported to have mild hearing difﬁculties,
likely to be coincidental, and no other additional clinical features
were noted. It is possible that these enhancers either act in a
slightly different way in humans compared to mouse and zebra-
ﬁsh, or there may be some redundancy given that several enhan-
cers have been identiﬁed for the same tissue, and single
enhancers have been observed in multiple tissues.6
Our whole genome sequencing demonstrates that, even at a
relatively low mean coverage (8 reads per base per proband), it
is possible to accurately resolve translocation or deletion break-
points. For proband 1 the genome sequencing was more
accurate than metaphase chromosome analysis and resulted in a
reassignment of the 7q breakpoint to the neighbouring chromo-
some band. The application of next generation sequencing for
precise characterisation of breakpoints is likely to ﬁnd clinical
utility as it can show whether the coding region of a candidate
disease gene is disrupted or, as in this study, identify the spatial
relationship between regulatory elements and their target genes.
The use of paired-end whole genome sequencing to map
rearrangement breakpoints to the exact nucleotide has previ-
ously been described for just seven patients.14–16 In all cases the
approximate location of the rearrangement, or at least the chro-
mosomes involved, was already known to the analysts, and one
of the next challenges is to be able to identify such rearrange-
ments without the need for prior cytogenetic testing. We used
the method developed by Nord et al8 to identify the causative
deletion in family 2. A number of different tools have been
described for detecting copy number variants (CNVs) from
exome data. Some have been successfully applied to discovering
CNVs in the general population17 18 or in multifactorial disease
cohorts,19 20 but there are very few examples of novel patho-
genic deletions causing monogenic disorders detected through
normalised read depth analysis of exome sequence data.21
In summary, by using exome sequencing copy number analysis
and whole genome sequencing to map deletion and transloca-
tion breakpoints, our study demonstrates that exonic enhancers
recently discovered through mouse and zebraﬁsh models are
also critical for limb development in humans.
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Figure 2 The full SHFM1 locus
showing the locations of the two
mutations identiﬁed in this study
relative to the previously published
mouse (E11.5) tissue-speciﬁc
enhancers. The deletion and
translocation breakpoints physically
separate tissue-speciﬁc enhancers from
DLX5/6 target genes. BA, Branchial
arch, FB, Forebrain; OV, Otic vesicle.
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